MEP of the week

Lobby organisation

BeOne Medicines I GmbH

Company · Health & pharma · HQ: Switzerland · Transparency Register entry

As of 7 November 2026, BeOne Medicines I GmbH appears in 7 declared MEP meetings (7 different MEPs), most often with European People's Party.

7
declared meetings
with current MEPs
7
MEPs met
€25k/yr
declared lobbying spend
self-reported to the register
0.5
lobbyists
full time equivalent

In their own words

“BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations.”

Read the rest of the statementShow less of the statement

“The Company has a growing global team of nearly 12,000 colleagues spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before.”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 7 declared meetings, by the meeting MEP's political group.

European People's Party343%
Renew Europe343%
Socialists & Democrats114%

Meetings by year

Declared meetings per calendar year, 2026–2026. Bar length is relative to its busiest year (7 in 2026). All meetings were in one calendar year. Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.

2026
7

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Andreas Glück
1 meeting · Renew
Sophie Wilmès
1 meeting · Renew
Oliver Schenk
1 meeting · EPP
Michalis Hadjipantela
1 meeting · EPP

The 7 most recent declared meetings

DateMEPSubject
16 Oct 2026Elena Nevado del CampoRetos en investigación y acceso innovación oncológica
12 Aug 2026Andreas GlückMDR IVDR Revision
6 May 2026Oliver Schenkoncology innovation and EU cancer policy
16 Apr 2026Sophie WilmèsCancer
16 Apr 2026Cynthia Ní MhurchúGeneral introduction and discussion on cancer policy
15 Apr 2026Michalis HadjipantelaIntroductory meeting
31 Mar 2026Vytenis Povilas AndriukaitisBiotech Act

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.